Person

Kim Kelderman

Chief Executive Officer · Director, Bio-Techne

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$2.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jan 27, 2025TECHSale11,731$77.19$906K
Jan 27, 2025TECHSale1,661$77.95$129K
Nov 19, 2021TECHSale400$505.78$202K
Nov 19, 2021TECHSale100$503.76$50K
Sep 22, 2021TECHSale822$529.04$435K
Jun 9, 2021TECHSale811$433.00$351K
May 25, 2021TECHSale845$424.00$358K
Feb 5, 2021TECHSale823$388.45$320K

SEC reporting-owner ID (CIK) 1739054 · all filings on EDGAR

Kim Kelderman (TECH) | USBoard